Japan Medical Cannabis Market was valued at USD 0.8 Billion in 2022 and is projected to reach USD 3.0 Billion by 2030, growing at a CAGR of 18.5% from 2024 to 2030.
Japan's medical cannabis market is slowly growing as the country begins to consider the potential benefits of medical marijuana for treating various health conditions. With stringent regulations and a deeply conservative society, the demand for medical cannabis in Japan remains low compared to countries like the United States or Canada. However, this market is witnessing gradual changes due to increasing interest from both patients and industries looking for alternative treatments.
Currently, Japan’s medical cannabis market is highly regulated. The Japanese government strictly controls cannabis use, only allowing it for medical purposes under specific circumstances. In 2018, Japan legalized the use of cannabis for medical treatments, but only under the prescription of licensed physicians. Despite this, the market remains in its infancy, with only a limited number of patients gaining access to cannabis-based treatments. This has resulted in a cautious approach from the pharmaceutical industry and other stakeholders.
One of the key industries driving the demand for medical cannabis in Japan is the pharmaceutical sector. With an aging population and a growing focus on chronic pain management, the industry is exploring alternative therapies that could provide relief for patients suffering from conditions such as cancer, multiple sclerosis, and epilepsy. The increasing need for innovative treatments is pushing pharmaceutical companies to look into medical cannabis as a potential solution.
Additionally, Japan's cannabis market has seen a rise in interest from the wellness and cosmetic industries. Cannabis-derived ingredients, such as CBD, are becoming popular in skincare products, as they are believed to offer anti-inflammatory and anti-aging benefits. This trend has attracted both local and international companies, who see the potential in tapping into the Japanese market.
Despite its potential, Japan's medical cannabis market faces several challenges. Cultural perceptions of cannabis as a harmful drug remain a significant barrier. Strict government regulations and the high cost of medical cannabis products also limit accessibility for patients. For the market to grow, there needs to be a shift in public perception and further regulatory developments to make cannabis-based treatments more accessible to those in need.
The medical cannabis market in Japan continues to evolve, and while it is still in its early stages, there is potential for growth. With increasing interest from the pharmaceutical and wellness industries, coupled with gradual regulatory changes, Japan may become an important player in the global medical cannabis market in the years to come.
Get an In-Depth Research Analysis of the Japan Medical Cannabis Market Size And Forecast [2025-2032]
BOL Pharma
Tilray
Medreleaf Corporation
Aurora Cannabis
Inc Canopy Growth Corporation
Insys Therapeutics
Inc Aphria
Inc MGC Pharmaceuticals Limited
GW Pharmaceuticals
plc
Medical Marijuana Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Medical Cannabis Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Medical Cannabis Market
Flower
Concentrates
Edibles
Tinctures
Topicals
Capsules
Dispensaries
E-commerce
Pharmacies
Specialty Stores
Direct Sales
Pain Management
Anxiety and Depression
Neurological Disorders
Cancer Treatment Support
Other Chronic Conditions
Cannabidiol (CBD)
Tetrahydrocannabinol (THC)
Full-Spectrum
Broad-Spectrum
Isolates
Millennials (18-34)
Generation X (35-54)
Baby Boomers (55+)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Medical Cannabis Market Research Analysis
1. Introduction of the Japan Medical Cannabis Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Medical Cannabis Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Medical Cannabis Market, By Type
6. Japan Medical Cannabis Market, By Application
7. Japan Medical Cannabis Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Medical Cannabis Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/